The US$44 million facility is part of Thermo Fisher's US$650 million multi-year investment. The state-of-the-art facility creates additional capacity to produce the high-quality technology and materials needed for the development of new vaccines and breakthrough therapies. In April 2022, Thermo Fisher Scientific opens its new single-use technology manufacturing site in Ogden, Utah. Biostat STR simplifies biologics production. In March 2020, Sartorius launched BIOSTAT STR Generation 3 single-use bioreactor and BIOBRAIN automation platform to introduce innovations that will change the field of biopharmaceutical process development and manufacturing.

PAT, which is strongly encouraged by global regulatory authorities, is a key enabler for real-time release and Bioprocessing 4.0. In June 2022, Merck has entered a collaboration with Agilent Technologies to advance Process Analytical Technologies (PAT). Leading players focus on expanding and diversifying their market presence and clientele, thereby tapping prevailing business opportunities. Merck KGaA, Sartorius AG, Thermo Fisher Scientific Inc, Corning Inc, STAMM Biotech, Lonza Group AG, Eppendorf SE, Repligen Corp, Danaher Corp, BioPharma Dynamics are among the key companies operating in the global bioprocess technology market. Global Bioprocess Technology Market: Competitive Landscape and Key Developments Merck KGaA, Sartorius AG, Thermo Fisher Scientific Inc, Corning Inc, STAMM Biotech, Lonza Group AG, Eppendorf SE, Repligen Corp, Danaher Corp, BioPharma Dynamics Ltdīrowse key market insights spread across 194 pages with 85 list of tables & 71 list of figures from the report, 'Bioprocess Technology Market Size and Forecast to 2028 - COVID-19 Impact and Global Analysis by Type (Cell Culture Media Bioprocess, Chromatography Bioprocess, Consumables & Accessories, and Others), Modality (Single Use and Multiple Use), and End User (Academic & Medical Institutions, Biopharmaceutical Companies, Research Laboratories, and Others)' in detail along with the table of contents: Bioprocess Technology Market Share Report – Reach $77.09 Billion by 2028 with 16.8% CAGR | Exclusive Research by The Insight Partners

Insight venture partners energy